Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Abnormal platelet aggregation associated with fluoxetine therapy.

C P Alderman1, C K Moritz, D I Ben-Tovim

  • 1Repatriation General Hospital, Daw Park, South Australia.

The Annals of Pharmacotherapy
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emergency department lengths of stay: characteristics favouring a delay to the admission decision as distinct from a delay while awaiting an inpatient bed.

Internal medicine journal·2014
Same author

Relationship between in-hospital location and outcomes of care in patients of a large general medical service.

Internal medicine journal·2013
Same author

The significance of reduced kidney function among hospitalized acute general medical patients.

QJM : monthly journal of the Association of Physicians·2012
Same author

Quality of resuscitation orders in general medical patients.

QJM : monthly journal of the Association of Physicians·2011
Same author

Resuscitation orders and their relevance to patients' clinical status and outcomes.

QJM : monthly journal of the Association of Physicians·2010
Same author

A brief analysis of clinical pharmacy interventions undertaken in an Australian teaching hospital.

Journal of quality in clinical practice·2002

Fluoxetine treatment can cause abnormal platelet aggregation, impacting hemostasis. This effect resolved rapidly after discontinuing the antidepressant, suggesting the parent drug was responsible.

Area of Science:

  • Pharmacology
  • Hematology
  • Clinical Medicine

Background:

  • Fluoxetine, a selective serotonin reuptuptake inhibitor (SSRI), is widely prescribed for depression.
  • SSRIs, including fluoxetine, are known to affect platelet function by inhibiting serotonin reuptake.
  • This inhibition can lead to decreased serotonin storage in platelets and alter their aggregation characteristics.

Observation:

  • A 49-year-old male patient experienced a release-type defect in platelet aggregation during fluoxetine therapy.
  • Platelet aggregation assays using various agonists (ADP, epinephrine, ristocetin, arachidonic acid, collagen) revealed abnormalities.
  • Platelet function normalized within two days of discontinuing fluoxetine.

Findings:

  • The observed rapid normalization of platelet aggregation upon fluoxetine withdrawal is inconsistent with the longer half-life of its active metabolite, norfluoxetine.

Related Experiment Videos

  • This suggests that the parent drug, fluoxetine, rather than norfluoxetine, was the primary cause of the hemostatic defect.
  • While serum concentrations were not measured, the clinical course points to the parent compound's role.

    • Implications:

    • This case highlights a potential, albeit reversible, hemostatic risk associated with fluoxetine use.
    • Clinicians should be aware of the possibility of drug-induced platelet dysfunction when prescribing fluoxetine.
    • Further research may be warranted to elucidate the precise mechanism and clinical significance of fluoxetine's effect on platelet aggregation.